Waltz Comments on Consolidation of Four CMS Anti-Fraud Programs Into One
08 November 2018
Bloomberg Law
Partner Judith Waltz was quoted in a Bloomberg Law article, “Medicare Herds Four Anti-Fraud Programs Under One Roof,” about a move by the Centers for Medicare & Medicaid Services to create one mega anti-fraud program out of four component programs.
Waltz said the new program will facilitate data sharing by removing some of the silos between Medicare and Medicaid. Many health-care providers and suppliers participate in both programs, she noted, and fraud, waste and abuse are likely to cross back and forth between the two. The Medicaid program also gets a lot of federal funding, she said, so the CMS has a vested interest in rooting fraud out of that program.
Waltz said the new program will facilitate data sharing by removing some of the silos between Medicare and Medicaid. Many health-care providers and suppliers participate in both programs, she noted, and fraud, waste and abuse are likely to cross back and forth between the two. The Medicaid program also gets a lot of federal funding, she said, so the CMS has a vested interest in rooting fraud out of that program.
People
Related News
12 May 2025
In the News
Judith Waltz Comments on Provider Settlement After Self-Disclosure
Foley & Lardner LLP partner Judith Waltz commented on a recent settlement by a provider with the U.S. Department of Health and Human Services Office of Inspector General (OIG) in the Report on Medicare Compliance article, "After Self-Disclosure, Provider Settles Case Over Failure to Report, Return Overpayments."
12 May 2025
In the News
Foley's Digital Infrastructure Arrivals Featured Across Legal Press
Foley & Lardner LLP partners Daniel Farris and Joe McClendon are featured in legal press for their arrival to the firm.
07 May 2025
In the News
Foley Attorneys Featured in Q&A on CPSC Oversight of Cosmetics Industry
Foley & Lardner LLP attorneys Erik Swanholt, Kristin McGaver, and Mikaela Mitchum are featured in a Cosmetics Design Q&A on what industry brands need to know regarding oversight from the U.S. Consumer Product Safety Commission.